Novo Nordisk Archives -

Novo Nordisk buys rights to NASH drug from Japan’s UBE

https://pharmaphorum.com/news/novo-nordisk-buys-rights-to-nash-drug-as/

Novo Nordisk builds in haemophilia with Bluebird Bio gene editing deal

https://pharmaphorum.com/news/novo-nordisk-builds-in-haemophilia-with-bluebird-bio-gene-editing-deal/

How to make digital adoption a smooth journey

https://pharmaphorum.com/views-analysis-sales-marketing/digital-adoption-smooth-journey/

Novo’s new oral GLP-1 Rybelsus still has obstacles to overcome

https://pharmaphorum.com/news/novos-new-oral-glp-1-still-has-obstacles-to-overcome/

The Pharma Comms Impact Conference – For Internal & External

https://pharmaphorum.com/events/the-pharma-comms-impact-conference-for-internal-external/

Novo and Sanofi make case for hypo-reducing insulins at EASD

https://pharmaphorum.com/news/novo-and-sanofi-duke-it-out-at-easd-making-case-for-hypo-reducing-insulins/

Novo Nordisk faces $1.8 billion lawsuit over US insulin sales

https://pharmaphorum.com/news/novo-nordisk-faces-1-8-billion-lawsuit-over-us-insulin-sales/

Novo extends R&D alliance with AI specialist e-Therapeutics

https://pharmaphorum.com/news/novo-extends-rd-alliance-with-ai-specialist-e-therapeutics/

Catalyst’s rival to NovoSeven hits the mark in phase 2 haemophilia trial

https://pharmaphorum.com/news/catalysts-rival-to-novoseven-hits-the-mark-in-phase-2-haemophilia-trial/

Search